CINECA IRIS Institutional Research Information System

AMBROGIO, Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2073
EU - Europa 1520
AS - Asia 516
OC - Oceania 11
AF - Africa 6
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4131
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2038
CN - Cina 347
IT - Italia 337
DK - Danimarca 222
SE - Svezia 205
IE - Irlanda 200
DE - Germania 122
UA - Ucraina 97
FR - Francia 80
AT - Austria 69
FI - Finlandia 61
KR - Corea 39
VN - Vietnam 39
CA - Canada 32
JP - Giappone 29
PL - Polonia 29
GB - Regno Unito 28
IN - India 24
BE - Belgio 19
ES - Italia 16
HK - Hong Kong 11
AU - Australia 9
PT - Portogallo 8
CH - Svizzera 6
TR - Turchia 5
GR - Grecia 4
MY - Malesia 4
SN - Senegal 4
TW - Taiwan 4
MK - Macedonia 3
NL - Olanda 3
NO - Norvegia 3
PH - Filippine 3
AM - Armenia 2
AR - Argentina 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
IL - Israele 2
MU - Mauritius 2
MX - Messico 2
NZ - Nuova Zelanda 2
PE - Perù 2
RU - Federazione Russa 2
TH - Thailandia 2
BA - Bosnia-Erzegovina 1
DO - Repubblica Dominicana 1
EU - Europa 1
ID - Indonesia 1
IR - Iran 1
KW - Kuwait 1
MO - Macao, regione amministrativa speciale della Cina 1
RO - Romania 1
SA - Arabia Saudita 1
Totale 4131
Salva come PNG Salva come JPEG
Città #
Ann Arbor 329
Chandler 324
Dublin 200
Beijing 195
Houston 128
Fairfield 120
Torino 113
Jacksonville 82
Wilmington 77
Ashburn 70
Vienna 67
Nyköping 66
Woodbridge 66
Cambridge 58
Princeton 53
Dearborn 45
Medford 43
Villeurbanne 43
Seattle 40
Turin 40
Boston 32
Dong Ket 29
Fremont 27
Warsaw 26
Shanghai 25
Pisa 24
Redwood City 22
Brussels 18
Boardman 16
Hangzhou 15
Grafing 13
San Diego 13
Falls Church 11
Rome 11
Tokyo 11
Chengdu 10
Guangzhou 10
Milan 10
Occimiano 10
Hefei 9
Trento 9
Aprilia 8
Munich 8
Ottawa 8
Central District 7
Norwalk 7
San Mateo 7
Chennai 6
Chicago 6
Dallas 6
Madrid 6
Montréal 6
El Paso 5
Kunming 5
Lissone 5
Nanjing 5
New York 5
Nürnberg 5
Saskatoon 5
Düsseldorf 4
Hyderabad 4
New Haven 4
Palaiseau 4
Raritan 4
Seoul 4
Silver Spring 4
Verona 4
Wuhan 4
Aurora 3
Baotou 3
Bari 3
Berlin 3
Buffalo 3
Changsha 3
Detroit 3
Frankfurt am Main 3
Guiyang 3
Göttingen 3
Hebei 3
Helsinki 3
Istanbul 3
Lanzhou 3
Liverpool 3
Melbourne 3
Mont-saint-aignan 3
Mumbai 3
Paris 3
Philadelphia 3
Phoenix 3
Redmond 3
San Jose 3
Shenyang 3
Southend 3
Stuttgart 3
Toronto 3
Varese 3
Victoria 3
Villadose 3
Witten 3
Zhengzhou 3
Totale 2752
Salva come PNG Salva come JPEG
Nome #
Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells 341
p130Cas mediates the transforming properties of the anaplastic lymphoma kinase 230
Negative feedback regulation of Rac in leukocytes from mice expressing a constitutively active phosphatidylinositol 3-kinase gamma 228
Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency 216
The anaplastic lymphoma kinase controls cell shape and growth of anaplastic large cell lymphoma through Cdc42 activation 214
Leukocyte transmigration is modulated by chemokine-mediated PI3Kgamma-dependent phosphorylation of vimentin 204
Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors 183
Redundant and non-redundant roles for Cdc42 and Rac1 in lymphomas developed in NPM-ALK transgenic mice 169
KRASQ61H preferentially signals through MAPK in a RAF dimer-dependent manner in non-small cell lung cancer 159
The EGFR family members sustain the neoplastic phenotype of ALK+ lung adenocarcinoma via EGR1. 110
Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma 90
Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-mediated signaling and anaplastic large cell lymphoma growth. 88
The Down syndrome critical region protein TTC3 inhibits neuronal differentiation via RhoA and Citron kinase 82
The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination 76
PPP4R2 regulates neuronal cell differentiation and survival, functionally cooperating with SMN. 73
ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasis 72
An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer 71
Molecola perturbation of IFNγR2 internalization reinstates T cell sensitività to the IFNγ/STAT1 signaling pathway in vitro and in vivo. 5th 70
Discoveries in the redox regulation of KRAS 70
Ablation of oncogenic ALK is a viable therapeutic approach fAblation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas 68
Expression of IFNgammaR2 mutated in a dileucine internalization motif reinstates IFNgamma signaling and apoptosis in human T lymphocytes 66
NPM-ALK oncogenic tyrosine kinase controls T-cell identity by transcriptional regulation and epigenetic silencing in lymphoma cells 65
A Braf kinase-inactive mutant induces lung adenocarcinoma 64
Human Wrnip1 is localized in replication factories in a ubiquitin-binding zinc finger-dependent manner 64
ERK inhibitor LY3214996-based treatment strategies for RAS-driven lung cancer 63
Increased Rrm2 gene dosage reduces fragile site breakage and prolongs survival of ATR mutant mice 61
Identification of genomic and proteomic signatures in lymphomas by inducible shRNA 60
The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration 59
Therapeutic inhibition of TRF1 impairs the growth of p53-deficient K-RasG12V-induced lung cancer by induction of telomeric DNA damage 59
Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma 55
The anaplastic lymphoma kinase in the pathogenesis of cancer 53
A putative role for Discoidin Domain Receptor 1 in cancer chemoresistance 53
Selective Therapeutic Targeting of the Anaplastic Lymphoma Kinase With Liposomal siRNA Induces Apoptosis and Inhibits Angiogenesis in Neuroblastoma. 52
Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma 52
TTC3 protein inhibits neuronal differentiation through RhoA and CITRON dependent mechanism 51
Simple and Rapid InVivo Generation of Chromosomal Rearrangements using CRISPR/Cas9 Technology 47
Lentiviral-based approach for the validation of cancer therapeutic targets in vivo 46
Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma 46
Comparative Analysis and Isoform-Specific Therapeutic Vulnerabilities of KRAS Mutations in Non-Small Cell Lung Cancer 45
How far we have come targeting BRAF-mutant non-small cell lung cancer (NSCLC) 42
MT1-MMP is required for myeloid cell fusion via regulation of Rac1 signaling. 38
Assessing therapeutic efficacy of MEK inhibition in a KrasG12C-driven mouse model of lung cancer 37
Docking Protein p130Cas Regulates Acinar to Ductal Metaplasia During Pancreatic Adenocarcinoma Development and Pancreatitis 36
TTC3 protein inhibits neuronal differentiation through a RhoA dependent mechanism 35
Impact of BRAF mutation class on disease characteristics and clinical outcomes in BRAF-mutant lung cancer 35
The Tyrosine Phosphatase SHP2 Interacts with NPM-ALK and Regulates Anaplastic Lymphoma Cell Growth and Migration. 34
Modeling lung cancer evolution and preclinical response by orthotopic mouse allografts 32
KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS 32
How to manage KRAS G12C-mutated advanced non-small-cell lung cancer 31
A structural model of a Ras–Raf signalosome 18
Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRASG12D-mutated non-small-cell lung cancer 17
Targeting Infrequent Driver Alterations in Non-Small Cell Lung Cancer 16
The Anti-Programmed Cell Death Protein-1/ Programmed Death-Ligand 1 Me-Too Drugs Tsunami: Hard To Be Millennials Among Baby Boomers 12
A LIBRETTO to orchestrate targeted therapy 5
Genomic Profiling Identifies Putative Pathogenic Alterations in NSCLC Brain Metastases 4
Totale 4299
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7268
article - articoli 0
book - libri 0
conference - conferenze 392
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7660
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018153 0000 00 00 8550144
2018/2019260 621812 415 2349 14315630
2019/2020780 12284553 64109 8463 101787667
2020/2021689 68407023 8130 4131 70736696
2021/2022922 80564967 4746 5863 5575202124
2022/2023972 12210625103 82278 10961 86000
Totale 4299